Lataa...
Quantification of neurological blood‐based biomarkers in critically ill patients with COVID‐19: Developing topics
BACKGROUND: Multiple neurological manifestations of COVID‐19 have been reported such as headache, anosmia, ischemic stroke, and cerebral hemorrhages. Objective characterization of the acute neurological damage in critically ill patients with COVID‐19 has not yet been reported. METHOD: We performed a...
Tallennettuna:
| Julkaisussa: | Alzheimers Dement |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7883192/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/alz.047682 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|